UNDCP. 2000. Executive summary of illicit drug supply, Iran. UNDCP. Tehran Iran. Walt V. 2001. Iran fears a flood of Afghan [ : mapinc drugnews v01 n178 a01 ?2055] drugs. USA Today Tuesday 16 October.
About us refills shipping information canadian pharmacies partners tell a friend aceon canadian pharmacy prices buy aceon canada drugs online home prescription drugs search view price quote how to order order form contact us faqs search rx · view price quote · complete drug list · drug index · how to order · order forms browse by a-z a our partner 20 popular drugs · accutane · provigil · haloperidol · vytorin · caduet · procarbazine · lyrica · atenolol · cephalexin · diovan · effexor · furosemide · lanoxin · lipitor · naproxen · paxil · premarin · prevacid · synthroid · trazodone · trazodone · wellbutrin sr · zithromax aceon buy aceon canada drugs online aceon perindopril - called coversyl ; 2mg price: $14 80 $12 91 usd quantity: 90 ready to order.
It is the intent of this Adult HIV Clinical Practice guideline to serve as a uniform, "best practice" minimum standard of care for adults with HIV infection. This guideline describes the best clinical practices based on available knowledge and a consensus of experts as of June 2000. It is recognized that not all recommendations are appropriate for all patients; these recommendations are not intended to substitute for the judgment of a physician or other health care provider who is an expert in the care of HIV-infected patients. When this is not possible, the physician treating the patient should have access to such expertise through consultations.
What is the effexor for and is there any contraindications between these 2 drugs.
Effexor pregnancy
Biovail pharmaceuticals inc in october 2000, we began executing our strategy of establishing a high calibre u.
Effexor alcohol, effexor fibromyalgia, drug effexor xr, effexor and menopause effexor alcohol, withdrawal symptoms of effexor, effexor xr side effects and elocon.
Lexapro vs effexor 10th march 2005.
Generic Effexor
| History of EffexorCuaderno N. 140: Pobreza infantil, conceptos, medicin y recomendaciones de polticas pblicas, Alberto Munujin, Enrique Delamnica, Alejandra Davidziuk. 1a edicin. Febrero 2006 $2.00 and evista, for example, effexor xl.
Generic Effexor
Target identification Drugs usually act on cellular proteins, such as enzymes or receptors, known as drug targets, which are believed to be associated with a disease. Scientists use a variety of molecular, genetic or pharmacological techniques to identify a target and learn more about how it influences the disease.
About integration of pharmacy benefit management. One holds that pharmacy services should not be separated from the larger medical benefit and flomax!
|
Call us toll-free 1-866-978-4944 home about us contact us shipping q& a shop all drugs allergies anti-depressants anti-infectives anti-psychotics anti-smoking antibiotics asthma cancer cardio & blood cholesterol diabetes epilepsy gastrointestinal hair loss herpes hiv hormonal men's health muscle relaxers other pain relief parkinson's rheumatic skin care weight loss women's health allegra atarax benadryl clarinex claritin clemastine periactin phenergan pheniramine promethazine zyrtec anafranil celexa cymbalta desyrel dosulepin effexor elavil, endep luvox moclobemide pamelor paxil prozac reboxetine remeron sinequan tianeptine tofranil wellbutrin zoloft albenza amantadine aralen flagyl grisactin isoniazid myambutol pyrazinamide sporanox tamiflu tinidazole vermox abilify clozaril compazine flupenthixol geodon haldol lamictal lithobid loxitane mellaril risperdal seroquel zyprexa nicotine nicotine polacrilex zyban achromycin augmentin bactrim biaxin ceclor cefepime ceftin chloromycetin cipro, ciloxan cleocin duricef floxin, ocuflox gatifloxacin ilosone keftab levaquin macrobid minomycin noroxin omnicef omnipen-n oxytetracycline prevpac rifater rulide suprax tegopen trimox vantin vibramycin zithromax advair aerolate, theo-24 brethine, bricanyl foradil ketotifen metaproterenol proventil, ventolin serevent singulair arimidex casodex decadron eulexin femara levothroid, synthroid nolvadex provera, cycrin ultram vepesid zofran acenocoumarol aceon adalat, procardia altace atenolol amlodipine avapro caduet calan, isoptin capoten captopril hctz cardizem cardura catapres cilexetil, atacand clonidine, hctz combipres cordarone coreg coumadin cozaar dibenzyline diovan fosinopril fosinopril hctz hydrochlorothiazide hytrin hyzaar inderal ismo, imdur isordil, sorbitrate lanoxin lasix lercanidipine lopressor lotensin lozol metoprolol hctz micardis minipress moduretic normadate norpace norvasc plavix plendil prinivil, zestril prinzide rythmol tenoretic tenormin trental valsartan hctz vaseretic vasodilan vasotec zebeta crestor lipitor lopid mevacor pravachol tricor zocor accupril actos alpha-lipoic acid amaryl avandia diamicron mr gliclazide metformin glucophage glucotrol glucotrol xl glucovance lyrica micronase orinase prandin precose starlix depakote dilantin lamictal neurontin sodium valproate tegretol topamax trileptal valparin aciphex antivert asacol bentyl cinnarizine colace colospa compazine cromolyn sodium cytotec imodium motilium nexium nexium fast pepcid ac pepcid complete prevacid prilosec propulsid protonix reglan stugil tagamet zantac zelnorm zofran propecia, proscar famvir rebetol valtrex zovirax combivir duovir-n epivir pyrazinamide retrovir sustiva triomune videx viramune zerit ziagen aldactone calciferol danocrine decadron prednisone provera, cycrin synthroid avodart cialis flomax hytrin levitra propecia, proscar viagra lioresal soma tizanidine ibuprofen zanaflex accupril alpha-lipoic acid amantadine aralen arcalion aricept ascorbic acid benadryl bentyl betahistine calciferol carbimazole compazine cyklokapron ddavp, stimate detrol dihydroergotoxine ditropan dramamine exelon florinef imitrex imuran isoniazid lasix melatonin myambutol nimotop orap persantine piracetam pletal quinine rifampin rifater rocaltrol sandimmune strattera ticlid tiotropium urecholine urispas urso vermox zyloprim acetylsalicylic acid advil, medipren celebrex flunarizine imitrex ketorolac maxalt ponstel tylenol ultram benadryl ditropan eldepryl requip sinemet trivastal advil, medipren arava colchicine decadron feldene indocin sr mobic naprelan naprosyn zyloprim betamethasone differin meticorten nizoral oxsoralen prograf retin-a xenical advil, medipren allyloestrenol clomid, serophene depo-provera diflucan drospirenone ethinyl estradiol evista folic acid fosamax isoflavone levonorgestrel lunelle nexium parlodel ponstel prevacid prilosec progesterone provera, cycrin rocaltrol tibolone generic cardizem generic name: diltiazem ; qty.
Fat but no evidence of regional adenopathy Fig. 1A ; . On other images superior to the image in Figure IA, the appendix was well visualized CD4 count agnosis anti-HIV AIDS-defining and appeared of 100 cells j.tl, even illness. He normal. to be positive which was allowed treated with a a diof an with and sulThe I-IIV test was found of AIDS medications and flonase.
It was previously available only under the brand names effexor and effexor xr.
Personal injury car accidents truck accidents motorcycle accidents school bus accidents slip and fall accidents dog bite incidents nursing home abuse social security disability ssdi & ssi medical negligence medical negligence cerebral palsy erbs palsy heart attack spinal meningitis work related injury workers' compensation carpal tunnel injuries drug litigation acetaminophen bextra cialis crestor cylert pemoline dilantin duragesic pain patch effexor enbrel ephedra fen phen pph fosamax gardasil ketek antibiotic meridia neurontin nexium palladone paxil permax ppa prevacid prilosec risperdal rocephin smith and nephew knee replacement thimerosal tylenol tysabri trasylol zelnorm zocor product liability complete moisture plus coli contamination guidant defibrillators heart stent kugel mesh patch medtronic defibrillators oxygen tank malfunction shelhigh medical devices harmful chemical exposure gadolinium - nsf, kidney failure benzene beryllium popcorn packers' lung product liability renu moistureloc welding parkinson's disease lead paint poisoning toxic mold financial matters bad faith insurance video messages legal glossaries disclaimer crestor lawyers: side effects & injury and flovent.
In children, before or during early puberty, moderateto high-impact weight-bearing exercise can increase bone mass by 5% over 6 months.11 Regular aerobic, weight-bearing and resistance exercise reduces bone loss in healthy adults, including postmenopausal women and can increase bone mass in adults by 1% to 3% over 12 years.10, 12, 13, for example, effexor pregnancy.
Drug Name Generics water Brands WATER Drug Tier 1 3 Req. Limits and fosamax.
An antigene drug in vivo. Previous studies have shown that N3'-P5' phosphoramidate PN ; backbone modification of TFO Fig. 1 ; increased the thermal stability of the pyrimidine motif triplex between a hornopurine-homopyrimidine target duplex and its specific cytosine-rich TFO at neutral pH 2 ; . Here, using a 23-bp target duplex and a 15-mer homopyrimidine TFO, I have examined the thermodynamic and kinetic effects of the PN backbone modification of TFO on the pyrimidine motif triplex formation at pH 6.8. The thermodynamic and kinetic properties have been analyzed by isothermal titration calorimetry ITC ; and interaction analysis system IAsys ; , respectively 3, 4 ; . I have found a significant effect of the PN backbone modification of TFO on the promotion of the pyrimidine motif triplex formation at neutral pH. MATERIALS AND METHODS I synthesized a 15-mer TFO, Pyrl5T: 5'-CTCTTCTTTT CTTTC-3', and complementary 23-mer DNA oligonucleotides, Pur23A: 5'-GCGCGAGAAGAAAAGAAAGCCGG-3' and Pyr23T: 5'-CCGGCTTTCTTTTCTTCTCGCGC-3', on a DNA synthesizer and purified them with a reverse-phase HPLC. A modified TFO with the same sequence as Pyrl5T but with PN backbone modification, Pyrl5NP, were synthesized as described previously 2 ; . Thermodynamic experiments were carried out on a MCS ITC system Microcal Inc., U. S. A. ; 3, 4 ; Kinetic analyses were performed on an, because weight loss and effexor xr.
The letter also asked for analyses for the cases identified using these approaches similar to those described above for Paxil. Re-Review of Suicidality Data from Pediatric Supplements for Other Antidepressants While we were waiting for the various sponsors of the antidepressants other than Paxil to respond with their summary data, we went back to the summary adverse event data in the pediatric supplements for these other drugs to re-examine the question of suicidality. The major question of interest was whether or not there were other antidepressants with possible signals of increased risk for suicidality, as was observed for Paxil. There were several limitations to this reexamination. First, the methods for detecting and coding events were not standard across these programs. Second, since we wanted to have similar numerator categories to those used for the Paxil data, for purposes of comparison across drug programs, we classified any events described in the adverse event listings, etc for these drug programs into the two categories of interest: "possibly suicide-related" and "suicide attempt." One obvious flaw in this approach was that the FDA reviewer was not blinded during this reclassification process. Nevertheless, it was hoped that this somewhat crude re-examination of these summary data might shed some light on the possibility of signals emerging from other antidepressant programs. While the methodology for this initial exploration was necessarily crude, it did provide some further insight into the treatment-emergent suicidality question across these 9 drug programs. There were several findings of particular interest resulting from this crude look at the pediatric supplements data. First, there were signals of increased risk of suicidality for patients assigned to drug for more than the paroxetine program, and second, the findings were not consistent across the studies even within individual programs. Finally, the signals were coming predominantly from the MDD studies within these programs. Wyeth Labeling Change and Dear Health Care Professional Letter for Effexor, and Regulatory Response During this period while we were re-examining the suicidality data from the pediatric supplements and beginning to receive responses to our requests for summary data from the sponsors for the other antidepressants, Wyeth, the sponsor for Effexog venlafaxine ; and Efgexor XR, decided to make labeling changes for its products with regard to suicidality and hostility. This action was and furosemide.
Discussion The effects of cocaine use during pregnancy have been evaluated in only small groups of patients. In a study of 23 maternal cocaine users and their infants, Chasnoff et al. [5] found four cases of abrupt onset of labor with placental abruption after IV cocaine use. They also found evidence of neurobehavioral effects of cocaine in the neonates of mothers who had abused the drug [5]. A case report describes perinatal cerebral infarction in an infant born to a mother who used cocaine on the day of delivery [7]. A further study of eight infants with positive nursery urine toxicology screens for cocaine showed "no evident symptomatology or signs of teratogenicity, " but the authors concluded that further evaluation was necessary [8]. Possible teratogenic effects of cocaine in humans have not been well documented. Two of our cases occurred at 1 9 menstrual weeks and one occurred at 32 weeks. The early abruptions resulted in fetal death in one case and in a voluntary therapeutic abortion in.
Categories ativan bactrim bromazepam buspirone carisoprodol celebrex citalopram clonazepam depakote diazepam dormicum effxor fludrocortisone flurazepam hydroxyzine imovane lasix levothyroxine lexotanil lipitor lorazepam meridia midazolam modafinil fda rx free naltrexone paxil phenergan propecia proscar provigil prozac risperdal rivotril sibutramine sildefil soma strattera tamiflu tegretol tramadol trazodone tryptanol valtrex viagra xenical zoloft zolpidem zyprexa zyrtec online ordering biaxin get without no required ; prescriptions and gemfibrozil.
`AMANDA' 2004 ; Members'notes 70. The Anxiety Community site accessed 27 February 2004. : anxietyhelp treatment medication eftexor ANONYMOUS 2004 ; `Brain Shivers'. What you get when you eat your ice cream too fast? Not hardly! About, Inc. Website accessed1March 2004. : depression.about cs venlafaxine a brainshivers 2 BRAINZAPS 2004 ; Brainzaps: a journal of Efrexor withdrawal. Brainzaps. Website accessed 27 February 2004. : brainzaps.tblog `CLAIRE' 2004 ; side-effects venlafaxine. SANE site discussion board. Last updated: Not stated. Accessed: 4 March 2004. : sane DiscussionBoard messages 498 DAZZI, L., VIGNONE, V., SEU, E., et al 2002 ; Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142. Journal of Psychopharmacology, 16, 125-131. `DDE' 2003 ; Brain shivers. The Dr. Bob Home Page site accessed1March 2004. : dr-bob curesites babble 20030520 msgs 227974 GIAKAS, W. J. & DAVIS, J. M. 1997 ; Intractable withdrawal from venlafaxine treated with fluoxetine. Psychiatric Annals, 27, 85-92. HAIN, T. C. & UDDIN, M. 2003 ; Pharmacological treatment of vertigo. CNS Drugs, 17, 85-100. `JJOHNSON' 2004 ; effexro withdrawals. Naturopathic Medicine Network site. Last updated: 1March 2004. Accessed: 1November 2004. : pandamedicine rt health 122-10-11 `KERRY' 1999 ; withdrawal symptoms. Rx List The Internet Drug Index site. Last updated: 29 December1999. Accessed: 5 November 2004. : rxlist rxboard effexor ?read 291.
ECENT reports have drawn attention to the problem of sexual dysfunction associated with chronic disease. Using specific questionnaires for women and men, sexual function scores were assessed in 43 sexually active patients with allergic rhinoconjunctivitis ARC ; . For both sexes, sexual function scores were significantly lower for patients with continued ARC symptoms than for patients receiving treatment for ARC or for healthy controls. Improvement in nasal and conjunctival symptoms was significantly correlated with improvement in sexual function scores. Sexual dysfunction is an important quality-of-life issue for patients with ARC, and one that can be improved with treatment to reduce allergic symptoms and glucophage and effexor, because lexapro vs effexor.
Wyeth is a research-based pharmaceutical company that funnels a significant percentage of its revenue each year to research and develop new drugs and new therapies for treating diseases. In the 1980s, Wyeth researchers developed venlafaxine as an unprecedented antidepressant that works by selectively inhibiting the neuronal reuptake of serotonin and norepinephrine, two naturally occurring neurotransmitters that have been implicated in depression and other mental disorders. Wyeth scientists recognized venlafaxine's promise as an important antidepressant medication and pressed forward with its development. Wyeth launched venlafaxine for the treatment of depression in the United States in early 1994 under the trade name Effexor. As originally launched, Egfexor was an immediate release dosage form. Although effective, it was not used in a wide-spread manner, primarily due to the side effects of nausea and vomiting. Patients who could benefit from this unique drug were deprived of an effective therapy due to these side effects. Wyeth researchers worked to develop an extended-release formulation that could provide adequate blood plasma levels of venlafaxine such that it could be taken once a day. This was a significant advance involving a sufficient inventive step to warrant a patent, since it was unknown if a once-a-day formulation would be therapeutically effective. Not only did Wyeth's research result in a formulation that could be administered once-a-day while maintaining efficacy, thereby making it more convenient for patients and improving compliance, but it also unexpectedly reduced side effects, such as nausea and emesis, as compared to the immediate release formulation. Venlafaxine is now widely prescribed because patients are able to adhere to the dosing regimen and tolerate therapeutic blood levels without lengthy and severe nausea. The ability of patients to benefit from the power of venlafaxine is to a large extent attributable to the efforts of Wyeth's work on the extended release formulation. Had Wyeth stopped its research efforts after discovering venlafaxine and launching Effexor, the true potential of this drug would never have been realized.
First Health Premier Drug Name cefaclor er cefadroxil cefazolin inj cefotaxime inj cefpodoxime proxetil CEFTIN SUSPENSION ceftriaxone cefuroxime cephalexin cefprozil chloramphen inj CIPRO SUSPENSION CIPRO XR ciprofloxacin clarithromycin CLEOCIN CLEOCIN PED CLEOCIN VAG clindamycin CLINDESSE colistimethate sodium cortomycin DAPSONE DAYTON SULFA demeclocycline hcl dicloxacillin sodium DISPERMOX DORYX doxy-caps doxycycline hyclate doxycycline monohydrate DURICEF DYNABAC e.e.s. 200 suspension e.e.s. 400 E.E.S. GRAN ees sulfisox E-MYCIN 333 ERY-TAB eryth sulfis ERYTHROCIN erythromycin FACTIVE FURADANTIN FUROXONE Drug Requirements Tier Limits 1 Drug Name GANTRIS PED garamycin inj gentamicin GEOCILLIN KETEK LEVAQUIN LEVAQUIN SOLN LORABID mandelamine MAXIPIME MAXAQUIN MEPRON methenam metronidazol mhp-a minocycline MONODOX MONUROL nafcillin inj NEGGRAM NEO-FRADIN neo poly hc neomycin NEOSPORIN GU IR SOLN NEUTREXIN nitrofur mac nitrofur mon ofloxacin OMNICEF oxacillin inj PANIXINE paromomycin PCE penicillin gk inj penicillin v potassium pen g sod inj PIPRACIL D5W PRIMAXIN PRIMSOL principen RANICLOR smz tmp ds smz-tmp grape suspension smz-tmp inj 5 Drug Requirements Tier Limits 3 1 First Health Premier Drug Name SPECTRACEF SULFADIAZINE sulfamethoxazole trimethoprim sulfatrim sulfisoxazol SUMYCIN SUSPENSION SUMYCIN SUPRAX tazicef inj TEQUIN tetracycline TINDAMAX TOBI 300 5ML TRAC trimethoprim trimox TYGACIL INJ urimar-t uritact ds urogesic-blue UROQID-ACID NO.2 usept UTA utira VANCOCIN HCL vancomycin iv vandazole gel VANTIN veetids VELOSEF VIBRAMYCIN XIFAXAN ZMAX ZYVOX ANTI-CONVULSANTS carbamazepine CARBATROL CELONTIN DEPACON DEPAKOTE DEPAKOTE SPR DILANTIN DILANTIN-125 epitol Drug Requirements Tier Limits 3 1 Drug Name ethosuximide FELBATOL gabapentin GABARONE GABITRIL KEPPRA LAMICTAL lamotrigine LYRICA NEURONTIN PEGANONE PHENYTEK phenytoin primidone TEGRETOL TEGRETOL XR TOPAMAX TRILEPTAL valproate sodium valproic acid ZARONTIN zonisamide ANTIDEMENTIA AGENTS ARICEPT COGNEX ergoloid mesylates EXELON NAMENDA RAZADYNE RAZADYNE ER ANTIDEPRESSANTS amitriptylin AMOXAPINE budeprion sr bupropion bupropion sr CELEXA SOLUTION citalopram tab clomipramine CYMBALTA desipramine doxepin hcl EFFEXOR EFFEXOR XR 6 Drug Requirements Tier Limits 1 3 1 QL, PA PA QL, PA QL ST PA, QL PA and glucotrol.
Home articles health topics diseases & conditions tests & procedures drugs & supplements symptoms site map quick links anxiety phobias ocd ptsd generalized anxiety disorder panic attacks agoraphobia social anxiety disorder anxiety symptoms paxil ativan fluoxetine effexor xr doxepin valium xanax clonazepam fluvoxamine a healthcare provider may prescribe fluvoxamine to treat adults, teens, and children who have obsessive-compulsive disorder ocd.
CDMA 1999 ; . Changes to Ontario Formulary will mean big savings for health care system. Viewpoint- News from Canada's National Pharmaceutical Industry, Winter 1999, 3-4. Collier, J. and Iheanacho, I. 2002 ; . The pharmaceutical industry as an informant, Lancet 260, 1405-09. Commission of the European Communities 1998 ; . Good manufacturing practices - medicinal products for human and veterinary use: European Commission - Directorate General III. Cookson, R., et al. 2001 ; . Wrong SIGN, NICE mess: is national guidance distorting allocation of resources?, BMJ, 323: 743-745. Council of the European Union 1989 ; . Council Directive 89 105 EEC, of 21 December 1988, relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion within the scope of national health insurance systems. Official Journal L 40, 11 February 1989. Danzon, P. M. 1998 ; . The Economics of Parallel Trade. Pharmacoeconomics, 13 3 ; : 293-304. De Vos, C.M. 1996 ; . The 1996 pricing and reimbursement policy in the Netherlands. Pharmacoeconomics, 10 Suppl ; : 75-80. DH UK ; 2001 ; . Options for the Future Supply and Reimbursement of Generic Medicines for the NHS: Department of Health UK July 2001. DHHS USA ; 2000 ; Prescription drug coverage, spending, utilization and prices: report to the President: Department of Health & Human Services US ; . Dingwall, D. 1997 ; Drug Costs in Canada. Submission by the Minister of Health to the House of Commons Standing Committee on Industry. Ministry of Health Canada ; . March 1997. Divine, G.W., et al. 1992 ; . The unit of analysis error in studies about physicians' patient care behaviour, Journal of General Internal Medicine, 7: 623-9. DKG. 1993 ; Survey by the German hospital association: DKG Germany ; . 17 December 1993. Dovey, S.M., et al. 2002 ; . A preliminary taxonomy of medical errors in family practice. Quality & Safety in Healthcare, 11 3 ; : 233-8. Drummond, M. and Pang, F. 2001 ; . Transferability of economic evaluation results, in Drummond M. and McGuire A. Eds. ; , Economic Evaluation in Healthcare: Merging Theory with Practice. Oxford: Oxford University Press. Drummond, M., et al. 1997 ; . Methods for the Economic Evaluation of Healthcare Programmes. Oxford: OUP. Drummond, M., et al. 1997 ; . The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy, 40 3 ; : 199-215 Drummond, M.F. 2003 ; . Will there ever be a European drug pricing and reimbursement agency? European journal of health economics, 4: 67-69. Duffy, A. 2001 ; Drug delays waste millions. The Ottawa Citizen. 1 May 2001. Edmunds, J. and Calnan, M.W. 2001 ; . The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practitioners in the United Kingdom, Social Science and Medicine, 53: 943-955. EGA 2002 ; . Data Exclusivity vs Bolar Provision: a false "trade-off". EGA Position Paper: European Generic medicines Association. EMEA. 2002 ; Human Medicines - Mutual Recognition Agreements. In: The European Agency for the Evaluation of Medicinal Products. European Commission 2003 ; . pict-pcti news archive 03 03Mar ECJ 031103 . ; Access Date: June 2003.
Alan Carter, Joseph Horn, Brett Plazek, Migirdech Tokat Project sub teams: Frame Aerodynamic Fairing Steering Drive-Train. Overall goals: Top 5 finish in the West Coast Competition, lightweight, responsive, comfortable, safe. Andrew Dockweiler, Dean Paraskevas, Dan Taylor Design a reliable and economical Interbox Connector with visual indicator for lock status. Analyze design with finite element software. Manufacture prototypes to test in the lab and in the field.
|
